How severe and prevalent are Ebola and Marburg viruses? A systematic review and meta-analysis of the case fatality rates and seroprevalence

Abstract Background Ebola and Marburg virus diseases are said to occur at a low prevalence, but are very severe diseases with high lethalities. The fatality rates reported in different outbreaks ranged from 24–100%. In addition, sero-surveys conducted have shown different seropositivity for both Ebo...

Full description

Bibliographic Details
Published in:	BMC Infectious Diseases
Main Authors:	Luke Nyakarahuka, Clovice Kankya, Randi Krontveit, Benjamin Mayer, Frank N. Mwiine, Julius Lutwama, Eystein Skjerve
Format:	Article
Language:	English
Published:	BMC 2016-11-01
Subjects:	Ebola virus disease Marburg virus disease Case fatality rate Meta-analysis Systematic review Seroprevalence
Online Access:	http://link.springer.com/article/10.1186/s12879-016-2045-6

Similar Items

A retrospective cohort investigation of seroprevalence of Marburg virus and ebolaviruses in two different ecological zones in Uganda
by: Luke Nyakarahuka, et al.
Published: (2020-07-01)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019-10-01)

Pygmy Populations Seronegative for Marburg Virus
by: Matthias Borchert, et al.
Published: (2005-01-01)

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
by: Anitha D. Jayaprakash, et al.
Published: (2023-01-01)

Immunogenicity of various variants of Ebola and Marburg virus glycoprotein genes in recombinant adenoviral vectors
by: T. A. Ozharovskaia, et al.
Published: (2024-10-01)

Animal models for Ebola and Marburg virus infections
by: Eri eNakayama, et al.
Published: (2013-09-01)

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse
by: Sophie J. Smither, et al.
Published: (2022-04-01)

Development of the Multiplex Real-Time PCR for Marburg, Ebola, and Lassa Viruses Identification
by: A. O. Sementsova, et al.
Published: (2011-06-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

Marburg Virus Disease: A Narrative Review
by: Arash Letafati, et al.
Published: (2025-05-01)

Experimental Success in Marburg Virus Vaccination
by: Martyna Dydyk, et al.
Published: (2024-09-01)

Marburg virus disease Mayhem: A new threat emerges in Rwanda
by: Pawan Kumar, et al.
Published: (2024-12-01)

Marburg haemorrhagic fever: A rare but fatal disease
by: G.A. Ogunbanjo
Published: (2005-05-01)

Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014–February 2015
by: Yngvar Lunde Haaskjold, et al.
Published: (2016-09-01)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
by: Ermela Paparisto, et al.
Published: (2021-09-01)

A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses
by: Takeshi Saito, et al.
Published: (2020-08-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014-07-01)

Outbreak of Marburg Virus Disease, Equatorial Guinea, 2023
by: Stephanie Ngai, et al.
Published: (2025-05-01)

Recent outbreak of Marburg virus disease: Could it be a threat for global public health?
by: Md. Sohan, et al.
Published: (2023-01-01)

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
by: Machteld M. Tiemessen, et al.
Published: (2022-08-01)

Evolution of Ebola and Marburg Treatment Centers Design, a Review of the Last Ten Years of Outbreaks in Africa
by: Luca Fontana, et al.
Published: (2024-10-01)

Can Marburg virus be sexually transmitted?
by: Hassan Karami, et al.
Published: (2024-08-01)

A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
by: Sarah Sebastian, et al.
Published: (2020-05-01)

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
by: Kaveesha J. Wijesinghe, et al.
Published: (2020-04-01)

Non-Ebola Filoviruses: Potential Threats to Global Health Security
by: Yannick Munyeku-Bazitama, et al.
Published: (2024-07-01)

Epidemiological dynamics of Ebola outbreaks
by: Thomas House
Published: (2014-09-01)

Marburg virus: an emerging global threat
by: Balamurugan Shanmugaraj
Published: (2024-09-01)

Spermatogenic transmission of Marbug and ebola virus
by: Sora Yasri, et al.
Published: (2015-03-01)

Isolated Case of Marburg Virus Disease, Kampala, Uganda, 2014
by: Luke Nyakarahuka, et al.
Published: (2017-06-01)

A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice
by: Jinhao Bi, et al.
Published: (2023-12-01)

Ebola Virus RNA in Semen from an HIV-Positive Survivor of Ebola
by: Lawrence J. Purpura, et al.
Published: (2017-04-01)

Case fatality rate for Ebola disease, 1976–2022: A meta-analysis of global data
by: Jonathan Izudi, et al.
Published: (2024-01-01)

Knowledge and attitude towards Ebola and Marburg virus diseases in Uganda using quantitative and participatory epidemiology techniques.
by: Luke Nyakarahuka, et al.
Published: (2017-09-01)

Marburg Virus Disease: Pathophysiology, Diagnostic Challenges, and Global Health Preparedness Strategies
by: Delfin Lovelina Francis, et al.
Published: (2025-06-01)

Marburg Virus Disease in Sub-Saharan Africa: A Review of Currently Available Comprehensive Genomic Data up to 2024
by: Edson Kinimi
Published: (2025-03-01)

Exposure-Specific and Age-Specific Attack Rates for Ebola Virus Disease in Ebola-Affected Households, Sierra Leone
by: Hilary Bower, et al.
Published: (2016-08-01)

A Novel Ebola Virus VP40 Matrix Protein-Based Screening for Identification of Novel Candidate Medical Countermeasures
by: Ryan P. Bennett, et al.
Published: (2020-12-01)

Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
by: Thomas L. Rudge, et al.
Published: (2022-07-01)

Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
by: Shriyansh Srivastava, et al.
Published: (2023-09-01)

Ebola outbreak 2014-2015: An update
by: Varun Goel, et al.
Published: (2015-01-01)